Candidemia in a Brazilian tertiary care hospital: Species distribution and antifungal susceptibility patterns

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 46, Issue 5, 2004, Pages 239-241

  Antunes, Ana Graciela Ventura ^a   Pasqualotto, Alessandro Comarú ^b   Diaz, María Cristina ^c   D'Azevedo, Pedro Alves ^a   Severo, Luiz Carlos ^b  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b Santa Casa Complexo Hospitalar   (Brazil)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Antifungal resistance; Candida species; Candidemia; Susceptibility tests

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ARTICLE; BRAZIL; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; DILUTION; DOSE RESPONSE; DRUG RESISTANCE; DRUG SENSITIVITY; FUNGEMIA; HOSPITAL; HUMAN; MINIMUM INHIBITORY CONCENTRATION;

EID: 8344251747     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46652004000500001     Document Type: Article

References (12)

1. COLOMBO, A.L.; NUCCI, M.; SALOMÃO, R. et al. - High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn. Microbiol. infect. Dis., 34: 281-286, 1999.
2. COLOMBO, A.L.; PERFECT, J.; DINUBILE, M. et al. - Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Europ. J. clin. Microbiol. infect. Dis., 22: 470-474, 2003.
3. COLOMBO, A.L.; NAKAGAWA, Z.; VALDETARO, F. et al. - Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals. Med. Mycol., 41: 235-239, 2003.
4. COSTA, S.F.; MARINHO, I.; ARAÚJO, E.A. et al. - Nosocomial fungaemia: a 2-year prospective study. J. Hosp. Infect., 45: 69-72, 2000.
5. EGGIMANN, P.; GARBINO, J. & PITTET, D. - Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet infect. Dis., 3: 685-702, 2003.
6. GODOY, P., TIRABOSCHI, I.N.; SEVERO, L.C. et al. - Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American Hospitals. Mem. Inst. Oswalde Cruz, 98: 401-405, 2003.
7. GOLDANI, L.Z. & MÁRIO, P.S.S. - Candida tropicalis fungemia in a tertiary care hospital. J. Infect., 46: 155-160, 2003.
8. MATSUMOTO, F.E.; GANDRA, R.F.; RUIZ, L.S. et al. - Yeasts isolated from blood and catheter in children from a public hospital of São Paulo, Brazil. Mycopathologia, 154: 63-69, 2001.
9. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS - Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standards. Wayne, NCCLS, 2002. (NCCLS document M27-A2).
10. PAPPAS, P.G.; REX, J.H.; LEE, J. et al. - A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin. infect. Dis., 37: 634-643, 2003.
11. PFALLER, M.A.; JONES, R.N.; DOERN, G.V. et al. - Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob. Agents Chemother., 44: 747-751, 2000.
12. PFALLER, M.A.; DIEKEMA, D.J.; JONES, R.N. et al. - International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J. clin. Microbiol., 39: 3254-3259, 2001.